Indeed, the serum levels of KL-6 exhibit a notable elevation in individuals grappling with an array of interstitial lung diseases, a cohort that prominently includes those bearing the burden of idiopathic pulmonary fibrosis [16,17]. This evidence concerns the gene MUC1 and interstitial lung disease.